BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006; 12(44): 7172-7178 [PMID: 17131482 DOI: 10.3748/wjg.v12.i44.7172] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy., European Helicobacter Study Group., European Society of Pathology., Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 389] [Cited by in F6Publishing: 344] [Article Influence: 38.9] [Reference Citation Analysis]
2 Heise K, Bertran E, Andia ME, Ferreccio C. Incidence and survival of stomach cancer in a high-risk population of Chile. World J Gastroenterol 2009; 15(15): 1854-1862 [PMID: 19370783 DOI: 10.3748/wjg.15.1854] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
3 Shan JH, Bai XJ, Han LL, Yuan Y, Sun XF. Changes with aging in gastric biomarkers levels and in biochemical factors associated with Helicobacter pylori infection in asymptomatic Chinese population. World J Gastroenterol 2017; 23(32): 5945-5953 [PMID: 28932086 DOI: 10.3748/wjg.v23.i32.5945] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
4 Sun L, Tu H, Liu J, Gong Y, Xu Q, Jing J, Dong N, Yuan Y. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population. Scand J Gastroenterol. 2014;49:1164-1172. [PMID: 25157583 DOI: 10.3109/00365521.2014.950693] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
5 Matamala-valdés L, Sánchez-alonzo K, Parra C, Sáez K, Aguayo-reyes A, García A. Detection of intracellular Helicobacter pylori in Candida. SPP from neonate oral swabs. Rev Assoc Med Bras 2018;64:928-35. [DOI: 10.1590/1806-9282.64.10.928] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis. 2008;40:523-530. [PMID: 18439884 DOI: 10.1016/j.dld.2008.02.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
7 Oliveros R, Pinilla Morales RE, Facundo Navia H, Sánchez Pedraza R. Cáncer gástrico: una enfermedad prevenible. Estrategias para intervención en la historia natural. Rev Colomb Gastroenterol 2019;34:177-89. [DOI: 10.22516/25007440.394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang X, Ling L, Li S, Qin G, Cui W, Li X, Ni H. The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis. Medicine (Baltimore) 2016;95:e3599. [PMID: 27149493 DOI: 10.1097/MD.0000000000003599] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Díaz Pérez JA, García Ramírez CA, Ferreira Bohorquez EJ, Rivero Rendon LA, Olarte Villamizar JM, Orozco Vargas LC. [Evaluation of endoscopic visualisation for identifying premalignant gastric lesions in a Columbian population using histopathology as a reference]. Aten Primaria 2009;41:85-9. [PMID: 19231703 DOI: 10.1016/j.aprim.2008.05.008] [Reference Citation Analysis]
10 Marques-Silva L, Areia M, Elvas L, Dinis-Ribeiro M. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2014;26:378-387. [PMID: 24569821 DOI: 10.1097/meg.0000000000000065] [Cited by in Crossref: 59] [Cited by in F6Publishing: 20] [Article Influence: 8.4] [Reference Citation Analysis]
11 Dinis-ribeiro M, Areia M, de Vries AC, Marcos-pinto R, Monteiro-soares M, O’connor A, Pereira C, Pimentel-nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-budnik T, Megraud F, Miki K, O’morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; on behalf of MAPS Participants. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19-46. [DOI: 10.1007/s00428-011-1177-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
12 Bellolio E, Riquelme I, Riffo-Campos AL, Rueda C, Ferreccio C, Villaseca M, Brebi P, Muñoz S, Araya JC. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System. Pathol Oncol Res 2019;25:1135-42. [PMID: 30467699 DOI: 10.1007/s12253-018-0532-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]